Cardiff Oncology Announces Settlement With Nerviano Medical Sciences And Amended 2017 Onvansertib License Agreement, Resolving All Litigation; Parties To Seek Dismissal With Prejudice

Loading news article.

Cardiff Oncology Announces Settlement With Nerviano Medical Sciences And Amended 2017 Onvansertib License Agreement, Resolving All Litigation; Parties To Seek Dismissal With Prejudice | WAPE

Cardiff Oncology Announces Settlement With Nerviano Medical Sciences And Amended 2017 Onvansertib License Agreement, Resolving All Litigation; Parties To Seek Dismissal With Prejudice

Article summary

Related companies

Analyzed by WAPE AI.

Comments —